FDA mandates stricter warning labels on opioids to address long-term use risks
13 Articles
13 Articles
FDA mandates stricter warning labels on opioids to address long-term use risks
The Food and Drug Administration will soon require drugmakers to place stronger warning labels on opioids to convey the risks associated with these medications.The labels will include clearer risk information about addiction, misuse, and overdose; stronger warnings regarding higher doses and their long-term risks; clarified use limits to prevent misinterpretation of long-term use; treatment guidance recommending long-acting opioids only if short…

FDA Mandates Major Labeling Changes On Opioid Pain Medication
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
FDA Mandates Major Labeling Changes On Opioid Pain Medication - Nemos News Network
The Food and Drug Administration is requiring pharma companies selling opioid pain medications to “better emphasize and explain the risks associated with their long-term use” on medication labels, the Department of Health and Human Services (HHS) said in a July 31 statement. “These changes follow a public advisory committee meeting in May that reviewed data showing serious risks—such as misuse, addiction, and both fatal and non-fatal overdoses—f…
Coverage Details
Bias Distribution
- 78% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium